Sign In
Buy AXGN
$42.21
+0.86 (+2.08%)
At Close: Jul 31, 2026
Canaccord Genuity Keeps a Buy Rating on AxoGen (AXGN)
11:15am, Tuesday, 25'th Feb 2020
In a report released yesterday, Kyle Rose from Canaccord Genuity reiterated a Buy rating on AxoGen (AXGN), with a price target of $22.00. The company's
Canaccord Genuity Keeps a Buy Rating on AxoGen (AXGN)
11:15am, Tuesday, 25'th Feb 2020
In a report released yesterday,
Kyle Rose
from Canaccord Genuity reiterated a
Buy
rating on AxoGen (
AXGN
–
Research Report
), with a price target of
$22.00
. The company’s shares closed last Mond
AxoGen, Inc. (AXGN) CEO Karen Zaderej on Q4 2019 Results - Earnings Call Transcript
03:14am, Tuesday, 25'th Feb 2020
AxoGen, Inc. (NASDAQ:AXGN) Q4 2019 Earnings Conference Call February 24, 2020 04:30 PM ET Company Participants Peter Mariani - Chief Financial Officer Karen Zad
AxoGen Inc (AXGN) Q4 2019 Earnings Call Transcript
03:00am, Tuesday, 25'th Feb 2020
AXGN earnings call for the period ending December 31, 2019.
AxoGen: 4Q Earnings Snapshot
09:25pm, Monday, 24'th Feb 2020
ALACHUA, Fla. (AP) _ AxoGen Inc. (AXGN) on Monday reported a loss of $7 million in its fourth quarter. On a per-share basis, the Alachua, Florida-based company said it had a loss of 18 cents. The re
Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results
09:01pm, Monday, 24'th Feb 2020
ALACHUA, Fla., Feb. 24, 2020 -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today.
Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results
09:01pm, Monday, 24'th Feb 2020
ALACHUA, Fla., Feb. 24, 2020 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions...
AxoGen (NASDAQ:AXGN) Stock Rating Upgraded by BidaskClub
09:54am, Monday, 24'th Feb 2020
BidaskClub upgraded shares of AxoGen (NASDAQ:AXGN) from a sell rating to a hold rating in a report issued on Thursday, BidAskClub reports. Several other equities research analysts have also recently i
AxoGen Reaffirms FY20 Sales Guidance Of $124M-$128M vs $131.75M Est.
12:00am, Monday, 24'th Feb 2020The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
11:38pm, Sunday, 23'rd Feb 2020
Biotech stocks turned in a lackadaisical performance last week amid earnings releases by smid-cap stocks, a few clinical readouts and data presentations at conferences and a handful of FDA verdicts. M
BerganKDV Wealth Management LLC Lowers Stock Holdings in AxoGen, Inc (NASDAQ:AXGN)
09:52am, Sunday, 23'rd Feb 2020
BerganKDV Wealth Management LLC decreased its position in shares of AxoGen, Inc (NASDAQ:AXGN) by 30.3% during the fourth quarter, HoldingsChannel reports. The firm owned 23,000 shares of the medical e
The Week Ahead In Biotech: Biopharma Earnings Pick Up Pace
12:00am, Sunday, 23'rd Feb 2020Analyzing AxoGen (NASDAQ:AXGN) and TransMedics Group (NASDAQ:TMDX)
07:42am, Saturday, 22'nd Feb 2020
AxoGen (NASDAQ:AXGN) and TransMedics Group (NASDAQ:TMDX) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their profit
AxoGen (AXGN) to Release Quarterly Earnings on Monday
06:24am, Saturday, 22'nd Feb 2020
AxoGen (NASDAQ:AXGN) is set to announce its earnings results after the market closes on Monday, February 24th. Analysts expect the company to announce earnings of ($0.14) per share for the quarter. In
AxoGen, Inc (NASDAQ:AXGN) Shares Acquired by Synovus Financial Corp
06:30pm, Friday, 21'st Feb 2020
Synovus Financial Corp lifted its position in shares of AxoGen, Inc (NASDAQ:AXGN) by 11.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities &
